T1	Participants 74 142	allergic rhinitis: study protocol for a randomized controlled trial.
T2	Participants 415 521	multicenter, randomized, controlled clinical trial on PER will be conducted at three institutions in China
T3	Participants 608 642	240 eligible participants with PER
